CureZone   Log On   Join

Pazopanib 400 mg: Therapy for RCC or STS by marykudro ..... Cancer Forum

Date:   10/19/2021 12:48:36 PM ( 3 months ago ago)
Hits:   49

0 of 0 (0%) readers agree with this message.  Hide votes     What is this?

Pazopanib 400 mg is indicated in adult patients for the first-line therapy of advanced renal cell carcinoma (RCC) who have previously received cytokine therapy for advanced disease. The pazopanib 400 mg is also indicated for treating adult recipients with selective subtypes of STS (advanced soft-tissue sarcoma) who have previously received chemo for their metastatic disease or who have progressed within one year following (neo) adjuvant therapy. Therapy with pazopanib should only be initiated by a health specialist experienced in the use of anti-cancer medicinal products. The standard dose of pazopanib for the treatment of RCC or STS is 800 mg orally once daily.


<< Return to the standard message view

fetched in 0.17 sec, referred by